MODIFICATION TO: STOCKERT S5 SYSTEM

K071318 · Sorin Group Deutschland GmbH · DTQ · Jul 6, 2007 · Cardiovascular

Device Facts

• Record ID: K071318
• Device Name: MODIFICATION TO: STOCKERT S5 SYSTEM
• Applicant: Sorin Group Deutschland GmbH
• Product Code: DTQ · Cardiovascular
• Decision Date: Jul 6, 2007
• Decision: SESE
• Submission Type: Special
• Regulation: 21 CFR 870.4220
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The modified S5 and Pulse Mode Control for the SCP/S5 are used with the SCP Rhythm System in conjunction with the Stöckert S5 System during cardiopulmonary bypass for procedures lasting six (6) hours or less.

Device Story

The Stöckert S5 System is a modular cardiopulmonary bypass heart-lung machine console. It consists of a central console, various pumps, monitors, displays, and user interfaces. The system is used in clinical settings during surgical procedures to provide extracorporeal circulation. The modified version includes Pulse Mode Control for the SCP/S5, designed to work with the SCP Rhythm System. The device is operated by trained medical professionals (e.g., perfusionists) to manage blood flow and physiological monitoring during bypass. The system provides real-time monitoring and control of perfusion parameters, allowing clinicians to maintain patient stability during surgery. The device benefits patients by supporting vital organ function during procedures where the heart and lungs must be bypassed.

Clinical Evidence

Bench testing only. Hardware and software testing demonstrated that the system fulfills prospectively defined performance specifications and meets user needs.

Technological Characteristics

Modular system comprising console, pumps, monitors, displays, and user interfaces. Operates as a cardiopulmonary bypass heart-lung machine. Software-controlled modules for rhythm and pulse mode management. Connectivity via integrated system bus. Class II device (21 CFR 870.4220).

Indications for Use

Indicated for patients undergoing cardiopulmonary bypass procedures lasting six hours or less, requiring use of the Stöckert S5 System in conjunction with the SCP Rhythm System and Pulse Mode Control.

Regulatory Classification

Identification

A cardiopulmonary bypass heart-lung machine console is a device that consists of a control panel and the electrical power and control circuitry for a heart-lung machine. The console is designed to interface with the basic units used in a gas exchange system, including the pumps, oxygenator, and heat exchanger.

Predicate Devices

• Stöckert S5 System (K062396)
• Stöckert S3 Roller Pump Module and Console (K950990)
• Stöckert SCP Rhythm Module (K042374)
• Stöckert S3 Cyclic RPM Control (K971520)

Submission Summary (Full Text)

{0}------------------------------------------------

K07/3/8

# 510(k) Summary Stöckert S5 System (per 21 CFR 807.92)

JUL -6 2007

#### SPONSOR 1.

Sorin Group Deutschland GmbH Lindberghstrasse 25 80939 Munich Germany Contact Person: Helmut Höfl Telephone: [phone]

May 9, 2007 Date Prepared:

# DEVICE NAME 2.

Stöckert S5 System Proprietary Name: Heart lung machine Common/Usual Name: Cardiopulmonary bypass heart-lung machine console and Classification Name: accessories

# 3. PREDICATE DEVICES

- Stöckert S5 System (K062396) .
- . Stöckert S3 Roller Pump Module and Console (K950990)
- . Stöckert SCP Rhythm Module (K042374)
- Stöckert S3 Cyclic RPM Control (K971520) .

# 4. DEVICE DESCRIPTION

The modified Stöckert S5 System, like the parent S5 System, is a modular system consisting of a console, various pumps, monitors, displays, controls, and user interfaces.

{1}------------------------------------------------

### 5. INTENDED USE

The modified S5 and Pulse Mode Control for the SCP/S5 are used with the SCP Rhythm System in conjunction with the Stöckert S5 System during cardiopulmonary bypass for procedures lasting six (6) hours or less.

#### TECHNOLOGICAL CHARACTERISTICS AND SUBSTANTIAL EQUIVALENCE 6.

The modified Stöckert S5 System is an upgrade of the parent Stöckert S5 System. The modified Stöckert S5 System is substantially equivalent to the parent Stöckert S5 System based on intended use, indication for use, operational characteristics, and fundamental technological characteristics.

#### PERFORMANCE TESTING 7.

Testing of the modified Stöckert S5 System (hardware and software) has demonstrated that the System fulfills prospectively defined performance specifications and that the modified System meets user needs.

{2}------------------------------------------------

Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized caduceus symbol, which is a staff with two snakes coiled around it, and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged in a circular fashion around the symbol. The caduceus is depicted with three curved lines representing the snakes and the staff, and the text is in a simple, sans-serif font.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

JUL -6 2007

Medical Device Consultant, Inc. c/o Ms. Rosina Robinson Principal Consultant, Regulatory Devices 49 Plain Street North Attleboro, MA 02760

Re: K071318

Stöckert S5 System Regulation Number: 21 CFR 870. 4220 Regulation Name: Cardiopulmonary bypass heart-lung machine console Regulatory Class: Class II (two) Product Code: DTQ Dated: June 21, 2007 Received: June 22, 2007

Dear Ms. Robinson:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{3}------------------------------------------------

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act): 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely vours.

Ashley B. Boane

for

Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

510(k) Number (if known):

Stöckert S5 System Device Name: _________________________________________________________________________________________________________________________________________________________________

Indications for Use:

The modified S5 and the Pulse Mode Control for the SCP/S5 are used with the SCP Rhythm System in conjunction with the Stöckert S5 System during cardiopulmonary bypass for procedures lasting six (6) hours or less.

Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR

Over-The-Counter Use (21 CFR 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Ahlee B. Evans for BDZ

of Cardiovascular Devices

510(k) Number K071318